Infection

, Volume 16, Issue 5, pp 273–276 | Cite as

Platelet factor 4 (PF 4) in septicaemia

  • R. Lorenz
  • M. Brauer
Originalia

Summary

The plasma concentrations of platelet factor 4 were measured in ten patients with septicaemia. In the acute phase the platelet factor 4 values were elevated (27.1±20.1 ng/ml; mean ± SD; normal values 4.7±1.2 ng/ml), and declined significantly after treatment with antibiotics and surgical therapy, respectively (10.6±7.3 ng/ml; p<0.005). The determination of prothrombin time, fibrinopeptide A, AT III and platelet counts demonstrated a coagulation disorder in the acute phase of septicaemia in all patients; a thrombocytopenia (<100,000/mm3) was observed in three cases. We suggest that the measurement of platelet factor 4 concentration could be useful as anin vivo indicator and as a follow-up parameter of increased platelet activation.

Plättchenfaktor 4 (PF 4) bei Septikämie

Zusammenfassung

Die Plasmakonzentration von Plättchenfaktor 4 wurde bei zehn Patienten mit Septikämie bestimmt. Während der akuten Erkrankungsphase waren die Plättchenfaktor-4-Werte erhöht (27,1±20,1 ng/ml; mean ± SD) und zeigten nach antibiotischer Behandlung beziehungsweise chirurgischer Therapie einen signifikanten Rückgang (10,6±7,3 ng/ml; p<0,005). Die Bestimmung von Quick-Test, Fibrinopeptid A, AT III sowie der Thrombozytenzahl ließ bei den untersuchten Patienten eine Gerinnungsstörung in der akuten Phase erkennen, eine Thrombopenie (<100 000/mm3) wurde in drei Fällen beobachtet. Es ist zu folgern, daß die Bestimmung der Plättchenfaktor-4-Konzentration alsIn vivo-Indikator und als Verlaufsparameter einer gesteigerten Plättchenaktivierung von klinischem Nutzen sein könnte.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Corrigan, J. J., Ray, W. L., May, N. Changes in blood coagulation system associated with septicemia. N. Engl. J. Med. 279 (1968) 851–853.Google Scholar
  2. 2.
    Jespersen, J., Rasmussen, N. R., Toftgard, C. Observations during the treatment with antithrombin-III concentrate of a case of tampon-related toxic shock syndrome and disseminated intravascular coagulation. Discrepancies between functional and immunologic determinations of antithrombin. Thromb. Res. 26 (1982) 457–462.Google Scholar
  3. 3.
    Lämmle, B., Tran, T. H., Ritz, R., Duckert, F. Plasma prekallikrein, factor XII, antithrombin III, C1-inhibitor and α2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am. J. Clin. Pathol. 82 (1984) 396–404.Google Scholar
  4. 4.
    Neame, P. B., Kelton, J. G., Walker, I. R., Stewart, I. O., Nossel, H. L., Hirsh, J. Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood 56 (1980) 88–92.Google Scholar
  5. 5.
    Spero, J. A., Lewis, J. H., Hariba, U. Disseminated intravascular coagulation. Findings in 346 patients. Thromb. Haemostas. 43 (1980) 28–33.Google Scholar
  6. 6.
    Ziemen, M., Fierek, N., Breddin, K. Hemostasis in septicemic patients with and without shock. Inn. Med. 14 (1987) 39–44.Google Scholar
  7. 7.
    Davis, R. B., Johnson, M. F. Effects of bacterial endotoxin and platelet activating factor (PAF) on human platelet aggregation in native whole blood. Thromb. Res. 44 (1986) 565–573.Google Scholar
  8. 8.
    MacVitte, T. J., Walker, R. I. Hematologic responses induced by endotoxin in normal and endotoxin tolerant dogs. Exp. Hematol. 8 (1980) 599–609.Google Scholar
  9. 9.
    Hawiger, J., Hawiger, A., Steckley, S., Timmons, S., Cheng, C. Membrane changes in human platelets induced by lipopolysaccharide endotoxin. Br. J. Haematol. 35 (1977) 285–299.Google Scholar
  10. 10.
    Stuart, M. J. Effect of endotoxin on arachidonic acid release and thromboxane B2 production by human platelets. Am. J. Haematol. 11 (1981) 159–164.Google Scholar
  11. 11.
    Kaplan, K. L., Owen, J. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activationin vivo. Blood 57 (1981) 199–202.Google Scholar
  12. 12.
    Clauss, A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. (Basel) 17 (1957) 237–246.Google Scholar
  13. 13.
    Lorenz, R., Sauer, M., Vogel, G. E.: Standardization of the collection of blood for the determination of the platelet factor 4 (PF 4). Haemostasis. Recent Advances and New Developments in Hemostaseology (1986) 63–64.Google Scholar
  14. 14.
    Pelzer, H., Fuhge, P., Heimburger, N. Enzymimmunoassay zur Bestimmung von humanem Plättchenfaktor 4 (abstr.). III. Kongreß für Thrombose und Blutstillung, Bern (1984).Google Scholar
  15. 15.
    Tanaka, H., Kobayashi, N., Maekawa, T. Effect of thrombin and endotoxin on thein vivo metabolism of antithrombin III (AT III) in dogs. Thromb. Res. 40 (1985) 291–306.Google Scholar
  16. 16.
    Tanaka, H., Kobayashi, N., Maekawa, T. Studies on production of antithrombin III with special reference to endotoxin-induced DIC in dogs. Thromb. Haemostas. 56 (1986) 137–143.Google Scholar
  17. 17.
    Bick, R. L., Bick, M., Fekete, L. F. Antithrombin III patterns in disseminated intravascular coagulation. Am. J. Clin. Pathol. 73 (1980) 577–583.Google Scholar
  18. 18.
    Schipper, H. G., Roos, J., V. D. Meulen, F., Ten Cate, J. W. Antithrombin III deficiency in surgical intensive care patients. Thromb. Res. 21 (1981) 73–80.Google Scholar
  19. 19.
    Dawes, J., Pumphrey, C. W., McLaren, K. M., Prowse, C. V., Pepper, D. S. Thein vivo release of human platelet factor 4 by heparin. Thromb. Res. 27 (1982) 65–76.Google Scholar
  20. 20.
    O'Brien, J. R., Etherington, M. D., Pashley, M. A. Intra-platelet factor 4 (IP-PF 4) and the heparin-mobilisable pool of PF 4 in health and atherosclerosis. Thromb. Haemostas. 51 (1984) 354–357.Google Scholar

Copyright information

© MMV Medizin Verlag GmbH München 1988

Authors and Affiliations

  • R. Lorenz
    • 1
  • M. Brauer
    • 1
  1. 1.II. Medizinische Klinik und Poliklinik der Technischen Universität MünchenMünchen 80

Personalised recommendations